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1. Introduction
In humans, the threshold of normal aging is accepted to involve the age of 60 years. At the 
same time, the age above the normal aging was divided into three subgroups, including 
young olds (65–75 years of age), old olds (75–85 years), and eldest olds (above 85 years of age) 
[1]. Normal aging is defined as weakening of the repair and defense processes of the body. 
The weakening of the defense in aging organism leads to increase in the level of toxic fac-
tors such as reactive oxygen species (ROS), calcium ions, and immuneinflammatory response. 
The consequence of the change in the level of these molecular factors is the development of 
age-related diseases, among others, atherosclerosis, tumors and neurodegenerative diseases. 
Simultaneously, ROS may lead to the damage of macromolecular compounds, such as lipids, 
proteins, and DNA [2, 3]. ROS may also play an important role in the modulation of transcrip-
tion factors activation, gene expression, and various life processes of a cell.
2. Genetic factors and normal aging
It seems that the aging process is determined by both changes in the levels of biochemical 
factors as well as multiple genetic variants. It is believed that normal aging is associated with 
genes such as SIRT1, AKT1 and CDKN1A, while longevity with e.g. FOXO3A and CETP. On 
the other hand, weakness of cognitive function during senescence may be modified by poly-T 
variants of TOMM40 and APOE alleles via influencing the level of apolipoprotein E [4, 5].
A detailed description of the molecular factors in aging process is provided in the chapter on 
genetic factors associated with longevity. According to the authors, longevity may be a complex 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
polygenic trait influenced by many genetic changes. In addition, longevity phenomena are influ-
enced by both epigenetic and environmental factors.
The aging process may be traced based on experimental models using candidate genes 
enabling early detection of aging before the emergence of typical phenotypes. Such experi-
mental model may be plants because they allow for the examination of complex mechanisms 
of molecular changes during aging.
In the last years, publications point to the involvement of many molecular factors in the devel-
opment of normal aging. However, we still did not prevent the pathological changes in the 
aging organism in the form of cardiologic, neurological, or oncological diseases.
3. Aging and old age diseases
In the aging process, functions of the p53 protein, genome trader, are impaired. The p53 pro-
tein does not lead to repair cells with damaged DNA or does not direct them to the path 
of apoptosis. The effect of these functional changes is increased susceptibility to infections, 
autoimmune diseases and cancers, including malignancies [1, 2]. The pathogenesis of tumors 
associated with the p53 protein is contained in this book.
In addition, older people often develop neurological diseases including Alzheimer’s and 
Parkinson’s diseases, epilepsy, and stroke. Based on the modern knowledge, it is difficult to 
separate normal and pathological aging, and neurodegeneration of central neurons. More 
information in the chapter, normal aging and neurodegenerative disorders.
The aging process is not limited to the central nervous system. It also includes other organs 
such as heart and liver. It is believed that the loss of liver regenerative capacity is disturbed 
in the elderly. Defective liver cells undergo apoptosis or aging. Aging cells are responsible for 
fibrosis and hepatocellular carcinoma. Is senescence important in hepatic diseases, available 
in this book.
Moreover, recently a growing interest focuses on senescent cells in the context of old age dis-
eases, malignancy and insulin resistance, and as a therapeutic goal to prolong health.
4. Summary
Despite current intensive research on the aging process, many questions about the pathomech-
anism of disorders in the old body remain unanswered. Moreover, the causes of unfavorable 
changes in the aging organism are not fully understood. It is not known which factors pre-
cisely define aging and/or longevity and contributes to the development of senility. Finding 
unknown paths in the pathogenesis of aging may improve the comfort of life of elderly and 
protect them from diseases typical for old age.
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